Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kaye Foster-Cheek Insider Profile
4 Followers
Kaye Foster-Cheek, Director at Agios Pharma, holds 5.48K shares in Agios Pharma (Ticker: AGIO), holds 5.80K shares in Johnson & Johnson (Ticker: JNJ), holds 0.00 shares in Onyx Pharma (Ticker: ONXX).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-6.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kaye Foster-Cheek holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kaye Foster-Cheek
Kaye Foster-Cheek's Trading History
Agios Pharma
Jun 01, 2020
Director
Uninformative Buy
―
$244.70K
Johnson & Johnson
Jan 04, 2010
VP HR
Uninformative Buy
―
$834.77K
Onyx Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Kaye Foster-Cheek's performance on stock
You May Also Like
Kaye Foster-Cheek insider profile FAQ
What is the percentage of profitable transactions made by Kaye Foster-Cheek?
The percentage of profitable transactions made by Kaye Foster-Cheek is 0%.
What is the average return per transaction made by Kaye Foster-Cheek?
The average return per transaction made by Kaye Foster-Cheek is -6.80%.
What stocks does Kaye Foster-Cheek hold?
Kaye Foster-Cheek holds: AGIO, JNJ, ONXX stocks.
What was Kaye Foster-Cheek’s latest transaction?
Kaye Foster-Cheek latest transaction was an Uninformative Buy of ―.
What was Kaye Foster-Cheek's most profitable transaction?
Kaye Foster-Cheek’s most profitable transaction was an Informative Sell of JNJ stock on December 11, 2009. The return on the trade was 0.00%.
What is Kaye Foster-Cheek's role in Agios Pharma?
Kaye Foster-Cheek's role in Agios Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.